Vice President, Analgesia Product Development
Michael Kuss, Vice President, Analgesia Product Development, leads an experienced group of scientific and regulatory professionals who provide sponsors with end-to-end support throughout their analgesia product development. Premier Research has developed multiple proprietary pain models that minimize the variability of subjective responses to pain, and that have become industry standards for analgesia research.
Prior to joining Premier Research, Mr. Kuss worked for Pharmacia (formerly G.D. Searle) in various positions with the last being Director of Research and Development. He was responsible for clinical development of several COX-2 inhibitors (celecoxib, valdecoxib and parecoxib) and NSAIDs (oxaprozin, oxaprozin potassium, diclofenac/misoprostol) as part of the Arthritis and Inflammation team. Prior to G.D. Searle, Mr. Kuss worked as a Clinical Research Associate at Abbott Laboratories and as an Infectious Diseases Research Technologist.
Mr. Kuss holds a bachelor’s degree in medical technology from Wright State University in Dayton, Ohio. He received a certification in medical technology from the American Society of Clinical Pathology.
In gravida lobortis libero, sit amet egestas elit malesuada a. Integer commodo nisi et elit dignissim pulvinar. Curabitur non ante lacus. Integer vehicula tortor lorem, ac fermentum tellus semper in.